Alkem Laboratories Reports Record Annual EBITDA Amidst Quarterly Profit Volatility: A Strategic Deep Dive into FY26 Performance
Mumbai, India — Alkem Laboratories, one of India’s leading pharmaceutical heavyweights, has concluded the 2025-26 financial year (FY26) on a complex note, characterized by a paradox of record-breaking operational efficiency…
